Dollarama Inc. (DLMAF)

Sage Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is March - February.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 5, 2025	Feb 2, 2025	Jan 28, 2024	Jan 29, 2023	Jan 30, 2022	Jan 31, 2021
Market Capitalization	38,012	26,341	20,591	17,257	14,985	12,134
Market Cap Growth	44.99%	27.92%	19.32%	15.16%	23.49%	13.70%
Enterprise Value	41,241	29,355	23,628	20,284	17,649	14,518
Last Close Price	138.85	94.17	73.52	61.64	49.93	38.45
PE Ratio	42.77	32.63	27.42	28.65	28.83	27.48
PS Ratio	8.03	5.95	4.72	4.55	4.42	3.85
PB Ratio	39.73	32.08	72.76	808.64	-289.57	46.32
P/TBV Ratio	127.55	136.26	-	-	-	-
P/FCF Ratio	35.78	26.64	21.68	31.26	18.70	20.72
P/OCF Ratio	31.26	23.19	18.10	26.44	16.50	17.45
EV/Sales Ratio	8.72	6.63	5.42	5.34	5.20	4.61
EV/EBITDA Ratio	26.18	25.04	20.86	21.79	21.04	18.57
EV/EBIT Ratio	31.83	26.88	22.39	23.56	22.82	20.05
EV/FCF Ratio	38.82	29.68	24.88	36.74	22.03	24.79
Debt / Equity Ratio	3.56	3.96	11.38	148.50	-54.77	10.34
Debt / EBITDA Ratio	2.33	2.40	2.46	2.90	2.86	2.94
Debt / FCF Ratio	3.20	3.29	3.39	5.74	3.54	4.62
Asset Turnover	1.08	1.09	1.16	1.14	1.05	1.01
Inventory Turnover	3.90	3.83	3.47	3.49	3.74	3.37
Quick Ratio	0.30	0.23	0.55	0.14	0.11	0.35
Current Ratio	1.31	1.18	1.93	1.00	0.79	0.83
Return on Equity (ROE)	140.36%	148.94%	493.80%	-	493.39%	465.14%
Return on Assets (ROA)	16.89%	16.82%	17.61%	16.13%	14.89%	14.57%
Return on Capital (ROIC)	18.46%	18.62%	19.81%	18.37%	16.79%	16.30%
Return on Capital Employed (ROCE)	29.00%	28.90%	31.00%	31.30%	31.30%	31.90%
Earnings Yield	2.34%	3.06%	3.65%	3.49%	3.47%	3.64%
FCF Yield	2.79%	3.75%	4.61%	3.20%	5.35%	4.83%
Dividend Yield	0.20%	0.27%	0.29%	0.27%	0.32%	0.36%
Payout Ratio	8.40%	8.32%	7.53%	7.85%	9.12%	9.71%
Buyback Yield / Dilution	0.74%	1.18%	2.35%	4.41%	2.57%	1.49%
Total Shareholder Return	0.95%	1.45%	2.63%	4.67%	2.89%	1.85%

Updated Dec 4, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.